Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies
Journal of Biochemical and Molecular Toxicology · 2025-11 · 39 (11)
DOI: 10.1002/jbt.70591 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 06.11.2025. Verfasst von Adnan Cetin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Education, Van Yuzuncu Yil University, Van, Türkiye. Hauptthemen laut MEDLINE: Triazines, Molecular Docking Simulation, Antineoplastic Agents, Drug Design. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben.
Abstract (Originalsprache)
1,2,4‐Triazines exhibit various pharmacological properties due to their strong biological activities, such as anticancer, anti‐inflammatory, antimicrobial, antiviral, and antioxidant, and also occupy an important place in the pharmaceutical field. The tested compounds were synthesized and characterized. 1,2,4‐Triazines were evaluated for their inhibitory and cytotoxicity effects on acetylcholinesterase (AChE), glutathione S‐transferase (GST), human liver cancer cell line (HepG2), and human colorectal adenocarcinoma cell line (HT‐29). 1,2,4‐Triazines ( 3a ‐ c , 5 , 6 , 10 ) were found to inhibit these enzymes with IC 50 values ranging from 1.41 to 4.28 μM for AChE and from 1.58 to 4.13 μM for GST. 1,2,4‐Triazine compounds were tested in range of 12.5−100 µM concentrations against HepG2 and HT‐29 cell lines. Among the 1,2,4‐triazines tested, 10 was the most effective substance on HepG2 cells, especially at high doses, while 3b was effective on HT‐29. Furthermore, molecular docking results indicated that the 1,2,4‐triazines showed strong binding and stability at the active site of enzymes and selected proteins. 1,2,4‐Triazines may serve as promising precursors for the design of potent enzyme inhibitors and anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Education, Van Yuzuncu Yil University, Van, Türkiye.
- Department of Medical Services and Techniques, Health Services Vocational School, Igdır University, Igdır, Türkiye.
- Institute of Chemical Sciences, University of Siedlce, Siedlce, Poland.
- Department of Basic Sciences, Faculty of Dentistry, Igdır University, Igdır, Türkiye.
- Department of Basic Medical Science, Medical of Faculty, Nakhichevan State University, Nakhichevan, Azerbaijan.
ORCID-Profile: Adnan Cetin
Zitieren
APA
Cetin, A., Oguz, E., Wolińska, E., Rozbicki, P., Branowska, D., & Türkan, F. (2025). Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology, 39(11). https://doi.org/10.1002/jbt.70591
Vancouver
Cetin A, Oguz E, Wolińska E, Rozbicki P, Branowska D, Türkan F. Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies. Journal of Biochemical and Molecular Toxicology. 2025;39(11). doi:10.1002/jbt.70591
BibTeX
@article{Cetin2025,
author = {Cetin, Adnan and Oguz, Ercan and Wolińska, Ewa and Rozbicki, Przemysław and Branowska, Danuta and Türkan, Fikret},
title = {Design, Synthesis, and Characterization of Novel Substituted 1,2,4‐Triazines: Cytotoxic Activity on HepG2 and HT‐29 Cell Lines, Enzyme Inhibition, and Molecular Docking Studies},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {11},
doi = {10.1002/jbt.70591}
}
EUVIMED